Lipid Nanoparticle (LNP) Encapsulation Capabilities
Offering cutting-edge Lipid Nanoparticle (LNP) encapsulation services can support a wide range of applications, including mRNA vaccines, addressing therapeutic areas such as infectious diseases, oncology, and rare diseases.
BioCina leverages advanced technologies and a highly skilled team to deliver high-quality, scalable LNP solutions tailored to your needs.
Advanced Encapsulation Technology
Utilizing Precision NanoSystems’ NanoAssemblr® platforms (Spark™, Ignite™, and Blaze™), we ensure efficient, scalable LNP production with high encapsulation efficiency and consistent particle size distribution for applications from preclinical to clinical and commercial stages.
Customised Formulations
We offer tailored LNP formulations to optimize product stability, delivery efficiency, and therapeutic performance, ensuring compliance with global regulatory standards.
Comprehensive Services for Your Every Need
Quality &
Regulatory
We produce mRNA drug substance of the highest quality standards, in full compliance with all global regulatory requirements.
Process
Development
BioCina’s expert Poly Nucleic Acid Products team is equipped to develop end-to-end mRNA manufacturing processes up to 1 L IVT and 1 L LNP encapsulation scale.
Analytical
Development
Robust and compliant test methods are developed to ensure the quality, safety and efficacy of all products manufactured at BioCina.
cGMP
Manufacturing
End-to-end cGMP manufacturing of LNP encapsulated mRNA, including cell line development and cGMP manufacture of template plasmid DNA.
Technology
Transfer
Our highly structured approach, including comprehensive gap analysis and robust risk mitigation, ensures reliable technology and process transfers.
Our Expertise On Demand
Thought Leadership & Resources
